Uncommon mutations in epidermal growth factor receptor and response to first and second generation tyrosine kinase inhibitors: A case series and literature review-Reference-Cited by-同舟云学术

Uncommon mutations in epidermal growth factor receptor and response to first and second generation tyrosine kinase inhibitors: A case series and literature review

Published:2018-01 Issue: Volume:115 Page:135-142
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Galli Giulia,Corrao Giulia,Imbimbo Martina,Proto Claudia,Signorelli Diego,Ganzinelli Monica,Zilembo Nicoletta,Vitali Milena,de Braud Filippo,Garassino Marina Chiara,Lo Russo Giuseppe

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference39 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Cancer,2015

2. The impact of personalized medicine on survival: comparisons of results in metastatic breast, colorectal and non-small-cell lung cancers;Rossi;Cancer Treat. Rev.,2014

3. Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap);Dearden;Ann. Oncol.,2013

4. Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy;Chalela;J. Thorac. Dis.,2017

5. Personalized therapy of non-small cell lung cancer (NSCLC);Gadgeel;Adv. Exp. Med. Biol.,2016

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simulation analysis of EGFR mutation detection: Oncomine Dx target test and AmoyDx panel impact on lung cancer treatment decisions;Scientific Reports;2024-01-18

2. EGFR Mutation Detection in Brazilian Patients With Non–Small-Cell Lung Cancer: Lessons From Real-World Data Scenario of Molecular Testing;JCO Global Oncology;2023-09

3. Successful treatment of lung adenocarcinoma complicated with a rare compound EGFR mutation L833V/H835L using aumolertinib: a case report and literature review;Frontiers in Pharmacology;2023-08-29

4. Overview on Therapeutic Options in Uncommon EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): New Lights for an Unmet Medical Need;International Journal of Molecular Sciences;2023-05-17

5. Case Report: Dacomitinib Overcomes Osimertinib Resistance in NSCLC Patient Harboring L718Q Mutation: A Case Report;Frontiers in Oncology;2021-12-02